Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada

Canadian Journal of Cardiology

Volumn 23, Issue 6, 2007, Pages 437-443

  Joffres, Michel R ^a   Campbell, Norm R C ^b   Manns, Braden ^c   Tu, Karen ^d  

^a SIMON FRASER UNIVERSITY   (Canada)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Blood pressure; Cost benefit analysis; Diet; Hypertension; Population health; Prevention; Sodium

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CANADA; CLINICAL TRIAL; CONSULTATION; COST CONTROL; COST OF ILLNESS; DIASTOLIC BLOOD PRESSURE; HEALTH CARE COST; HUMAN; HYPERTENSION; LABORATORY TEST; POPULATION RESEARCH; PREVALENCE; SODIUM INTAKE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH PROMOTION; HEALTH SURVEY; NUTRITIONAL REQUIREMENT;

CANADA; COST-BENEFIT ANALYSIS; DIET, SODIUM-RESTRICTED; HEALTH CARE COSTS; HEALTH PROMOTION; HEALTH SURVEYS; HUMANS; HYPERTENSION; NUTRITIONAL REQUIREMENTS; POPULATION SURVEILLANCE; PREVALENCE; SODIUM, DIETARY;

EID: 34250640717     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(07)70780-8     Document Type: Article

References (51)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJLM; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-60.
2. Lawes CMM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels. J Hypertens 2006;24:413-22.
3. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9.
4. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997;10:1097-102.
5. World Health Organization. The world health report 2002 - reducing risks, promoting healthy life. Geneva, Switzerland. (Version current at March 9, 2007).
6. Mohan S, Campbell N, Chockalingam A. Management of hypertension in low and middle income countries: Challenges and opportunities. Prev Control 2005;1:275-84.
7. Whelton PK, He J, Appel LJ, et al; National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002;288:1882-8.
8. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23.
9. Chockalingam A, Balaguer-Vintro I. Impending Global Pandemic of Cardiovascular Diseases. Barcelona: Prous Science, 1999.
10. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-10.
11. Khan NA, McAlister FA, Rabkin SW, et al; Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - therapy. Can J Cardiol 2006;22:583-93.
12. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-72. (Erratum in 2003;290:197).
13. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53. (Errata in 2003;21:2203-4, 2004;22:435).
14. Williams B, Poulter NR, Brown MJ et al; British Hypertension Society. Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. J Hum Hypertens 2004;18:139-85.
15. Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials. J Hypertens 2006;24:215-33.
16. Advisory Board of the Second International Heart Health Conference. The Catalonia Declaration. Investing in heart health. 1995:1-85. (Version current at March 9, 2007).
17. Advisory Board of the International Heart Health Conference. The Victoria Declaration on Heart Health. 1992:1-56. (Version current at March 9, 2007).
18. Scientific Advisory Committee on Nutrition. Salt and Health. 2003:1-134. (Version current at March 9, 2007).
19. American Public Health Association. Reducing sodium content in the American diet. American Public Health Association - Association News 2002. 2002 Policy statements: 5-6.
20. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM; American Heart Association. Dietary approaches to prevent and treat hypertension: A scientific statement from the American Heart Association. Hypertension 2006;47:296-308.
21. Council on Science and Public Health. Report 10 of the Council on Science and Public Health (A-06). Promotion of Healthy Lifestyles I: Reducing the population burden of cardiovascular disease by reducing sodium intake. American Medical Association, 2006.
22. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride and Sulfate. Washington: National Academies Press, 2004:1-640.
23. Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr 1991;10:383-93.
24. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004;(3):CD004937. (Updated in 2006)
25. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 1992;146:1997-2005.
26. MacLean DR, Petrasovits A, Nargundkar M, et al. Canadian heart health surveys: A profile of cardiovascular risk. Survey methods and data analysis. Canadian Heart Health Surveys Research Group. CMAJ 1992;146:1969-74.
27. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials. BMJ 2003;326:1427-34.
28. Tu K, Campbell NRC, Durong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002. Hypertension 2005;45:1113-8.
29. Beland Y. Canadian community health survey - methodological overview. Health Rep 2002;13:9-14.
30. Onysko J, Maxwell C, Eliasziw M, Zhang J, Johansen H, Campbell NR; Canadian Hypertension Education Program. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 2006;48:853-60.
31. IMS Health Canada. Canadian Disease and Therapeutic Index, 2003.
32. Ontario Ministry of Health and Long-Term Care. Schedule of benefits: Physician services under the Health Insurance Act. Toronto, 2003.
33. Tu K, Campbell NRC, Chen Z, Cauch-Dudek KJ, McAlister FA. Validation of administrative databases in identifying patients with hypertension. Open Med 2007. (In press)
34. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario. Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-6.
35. van Walraven C, Goel V, Chan B. Effect of population-based interventions on laboratory utilization: A time-series analysis. JAMA 1998;280:2028-33. (Erratum in 2000;283:481).
36. van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem 2003;49:1997-2005.
37. IMS Health Canada, Canadian CompuScript Audit, 2003.
38. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002;325:628-37.
39. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006;49:59-75.
40. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ 1993;149:289-93.
41. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
42. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003;42:1093-9.
43. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978;299:741-4.
44. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Erratum in 2003;361:1060).
45. Hollenberg NK. The influence of dietary sodium on blood pressure. J Am Coll Nutr 2006;25:240S-6S.
46. He FJ, MacGregor GA. Importance of salt in determining blood pressure in children: Meta-analysis of controlled trials. Hypertension 2006;48:861-9.
47. Obarzanek E, Proschan MA, Vollmer WM, et al. Individual blood pressure responses to changes in salt intake: Results from the DASH-Sodium trial. Hypertension 2003;42:459-67.
48. Cook NR, Cohen J, Hebert P, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995;155:701-9.
49. The Salt Institute. (Version current at March 12, 2007).
50. Cook NR, Cutler JA, Obarzanek E, et al. The effects of dietary sodium reduction on cardiovascular disease: Long-term follow-up of the Trials of Hypertension Prevention. J Hypertens 2006;24:S141.
51. Chang H-Y, Hu Y-W, Yue C-SJ, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr 2006;83:1289-96.